Miller Value Partners TEVA-OLD trades
Bill Miller
Bill Miller Teva Pharma Industries Ltd ADR stake
total: 463
Trades details
- Total transactions:
- 28
- New positions:
- 1
- Sold out:
- 1
- Added:
- 12
- Reduced:
- 14
- Held since:
- 2017 Q4
- Held for:
- 29 quarters
- Latest activity:
- 2025 Q1
According to 2026 Q2 report, Bill Miller doesn't hold any Teva Pharma Industries Ltd ADR (TEVA-OLD) shares. To date, the estimated cost basis is nearly $12.64 for "buy" trades and estimated average "sell" price is $8.67. Miller Value Partners first purchased TEVA-OLD in 2017 Q4, initially acquiring 516,112 shares. Since the initial investment in Teva Pharma Industries Ltd ADR (TEVA-OLD), Miller Value Partners has made 27 more transactions.
When did Bill Miller sell Teva Pharma Industries Ltd ADR (TEVA-OLD)?
Bill Miller sold off the entire Teva Pharma Industries Ltd ADR (TEVA-OLD) position in 2025 Q1.
When did Bill Miller buy Teva Pharma Industries Ltd ADR (TEVA-OLD)?
Bill Miller first invested in Teva Pharma Industries Ltd ADR (TEVA-OLD) in 2017 Q4 at the reported quarter-end price of $18.95 per share.
What's the cost basis of Miller Value Partners's TEVA-OLD stake?
The estimated cost basis for Teva Pharma Industries Ltd ADR (TEVA-OLD) stake is around $12.64 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $12.64
- Weighted AVG sell price:
- $8.67
Bill Miller's historical trades in Teva Pharma Industries Ltd ADR
28 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q1
|
0.00%
|
0
|
$22.04
|
|
-100% (-10,950)
|
-0.1%
|
|
2024 Q2
|
0.11%
|
10,950
|
$16.25
|
$177,937
|
-5.60% (-650)
|
-0.01%
|
|
2024 Q1
|
0.10%
|
11,600
|
$14.11
|
$163,676
|
-13.43% (-1,800)
|
-0.02%
|
|
2023 Q4
|
0.08%
|
13,400
|
$10.44
|
$139,896
|
-5.80% (-825)
|
-0.01%
|
|
2023 Q3
|
0.09%
|
14,225
|
$10.20
|
$145,095
|
-82.68% (-67,912)
|
-0.46%
|
|
2023 Q2
|
0.41%
|
82,137
|
$7.53
|
$618,492
|
-97.91% (-3,847,647)
|
-1.81%
|
|
2023 Q1
|
2.17%
|
3,929,784
|
$8.85
|
$34,778,588
|
-23.65% (-1,217,243)
|
-0.7%
|
|
2022 Q4
|
3.03%
|
5,147,027
|
$9.12
|
$46,940,886
|
-44.39% (-4,107,848)
|
-2.28%
|
|
2022 Q3
|
4.54%
|
9,254,875
|
$8.07
|
$74,687,000
|
-0.85% (-79,715)
|
-0.04%
|
|
2022 Q2
|
3.93%
|
9,334,590
|
$7.52
|
$70,196,000
|
-7.20% (-724,149)
|
-0.21%
|
|
2022 Q1
|
3.58%
|
$9.39
|
+4.13% (+399,220)
|
|||
|
2021 Q4
|
2.74%
|
$8.01
|
-0.91% (-88,610)
|
|||
|
2021 Q3
|
3.23%
|
$9.74
|
-10.86% (-1,187,654)
|
|||
|
2021 Q2
|
2.82%
|
$9.90
|
+3.62% (+381,718)
|
|||
|
2021 Q1
|
3.46%
|
$11.54
|
+47.82% (+3,414,365)
|
|||
|
2020 Q4
|
2.33%
|
$9.65
|
-11.79% (-953,998)
|
|||
|
2020 Q3
|
2.89%
|
$9.01
|
+3.10% (+243,226)
|
|||
|
2020 Q2
|
4.30%
|
$12.33
|
-0.86% (-67,890)
|
|||
|
2020 Q1
|
4.57%
|
$8.98
|
-19.48% (-1,915,705)
|
|||
|
2019 Q4
|
3.44%
|
$9.80
|
+15.82% (+1,342,915)
|
|||
|
2019 Q3
|
2.36%
|
$6.88
|
+30.63% (+1,990,900)
|
|||
|
2019 Q2
|
2.40%
|
$9.23
|
+43.10% (+1,957,720)
|
|||
|
2019 Q1
|
2.83%
|
$15.68
|
+16.12% (+630,730)
|
|||
|
2018 Q4
|
2.75%
|
$15.42
|
+0.16% (+6,350)
|
|||
|
2018 Q3
|
2.74%
|
$21.54
|
+50.87% (+1,316,840)
|
|||
|
2018 Q2
|
2.37%
|
$24.32
|
+17.93% (+393,640)
|
|||
|
2018 Q1
|
1.61%
|
$17.09
|
+325.29% (+1,678,860)
|
|||
|
2017 Q4
|
0.42%
|
$18.95
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.